Buscar
Mostrando ítems 1-1 de 1
Mrna vaccines against sars-cov-2: advantages and caveats
(MDPI, 2023)
Artículo / Artikulua,
The application of BNT162b2 and mRNA-1273 vaccines against SARS-CoV-2 infection
has constituted a determinant resource to control the COVID-19 pandemic. Since the beginning of
2021, millions of doses have been administered ...